1. Signaling Pathways
  2. Cytoskeleton
  3. Dystrophin

Dystrophin

Dystrophin is a rod-shaped cytoskeletal protein that connects the intercellular cytoskeleton to the extracellular matrix through an actin-associated glycoprotein complex. This property enables Dystrophin to play a role in sarcolemmal stability during muscle contraction and prevent contraction damage. Dystrophin also mediates cell signaling, such as mechanotransduction and cell adhesion. However, Dystrophin deficiency or mutation (producing internally truncated Dystrophin) will become a predisposing factor for Duchenne muscular dystrophy (DMD). In the muscle tissue of mild and asymptomatic patients, a large number of alternative Dystrophin splicing protein products can be detected. Currently, the methods for restoring Dystrophin mutations rely on virus-mediated restoration or exon skipping. Exon skipping uses antisense oligonucleotides to induce alternative splicing, bypassing the mutated exon to restore the protein reading frame, and converting DMD mutations to Becker muscular dystrophy (BMD) protein mutations.
Dystrophin-related proteins can be divided into three groups (according to subcellular localization): (1) α-dystroglycan located outside the cell; (2) β-dystroglycan, sarcoglycans, and sarcospan located on the plasma membrane; (3) Dystrophin, dystrobrevin, syntrophins, and neuronal nitric oxide synthase located inside the cell. Dystrophin has four major functional domains: the actin-binding amino-terminal domain (ABD1), the central rod domain, the cysteine-rich domain, and the carboxyl terminus. Dystrophin interacts with tubulin and acidic actin filaments through the rod domain, so Dystrophin mutations not only lead to progressive loss of muscle tissue and function, but also cause cardiomyopathy[1][2][3].

Dystrophin Related Products (25):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-132586A
    Viltolarsen sodium
    Modulator
    Viltolarsen (NS-065/NCNP-01) sodium is a phosphorodiamidate morpholino antisense oligonucleotide. Viltolarsen sodium binds to exon 53 of the dystrophin mRNA precursor and restores the amino acid open-reading frame by skipping exon 53, resulting in the production of a shortened dystrophin protein that contains essential functional portions. Viltolarsen sodium has the potential for Duchenne muscular dystrophy (DMD) research.
    Viltolarsen sodium
  • HY-132586
    Viltolarsen
    Modulator
    Viltolarsen (NS-065/NCNP-01) is a phosphorodiamidate morpholino antisense oligonucleotide. Viltolarsen binds to exon 53 of the dystrophin mRNA precursor and restores the amino acid open-reading frame by skipping exon 53, resulting in the production of a shortened dystrophin protein that contains essential functional portions. Viltolarsen has the potential for Duchenne muscular dystrophy (DMD) research.
    Viltolarsen
  • HY-132611
    Golodirsen
    Modulator
    Golodirsen (SRP-4053) is an antisense oligonucleotide of the phophorodiamidate morpholino oligomer (PMO). Golodirsen restores the reading frame of the Duchenne muscular dystrophy (DMD) gene by modifying the splicing process of the pre-mRNA, skipping exon 53. Golodirsen can restore the expression of the anti-myostatin protein. Golodirsen can be used for the research of duchenne muscular dystrophy (DMD).
    Golodirsen
  • HY-132611A
    Golodirsen sodium
    Modulator
    Golodirsen (SRP-4053) sodium is an antisense oligonucleotide of the phophorodiamidate morpholino oligomer (PMO). Golodirsen sodium restores the reading frame of the Duchenne muscular dystrophy (DMD) gene by modifying the splicing process of the pre-mRNA, skipping exon 53. Golodirsen sodium can restore the expression of the anti-myostatin protein. Golodirsen sodium can be used for the research of duchenne muscular dystrophy (DMD).
    Golodirsen sodium
  • HY-145724
    Drisapersen
    Inducer
    Drisapersen (Kyndrisa) is a 2'-O-methyl phosphorothioate RNA antisense oligonucleotide that induces exon 51 skipping. Drisapersen induces skipping of exon 51 during Dystrophin pre-mRNA splicing, allowing the synthesis of partially functional Dystrophin. Drisapersen can be used in research related to Duchenne muscular dystrophy.
    Drisapersen
  • HY-177649B
    Nivudirsen sodium scrambled negative control
    Inhibitor
    Nivudirsen sodium scrambled negative control is the sequence scrambled negative control of Nivudirsen sodium.
    Nivudirsen sodium scrambled negative control
  • HY-185321
    Tacadirsen
    Inducer
    Tacadirsen is an oligonucleotide that can promote the synthesis of functional dystrophin synthesis, and is used for the research of Duchenne muscular dystrophy.
    Tacadirsen
  • HY-185321A
    Tacadirsen sodium
    Inducer
    Tacadirsen sodium is an oligonucleotide that can promote the synthesis of functional dystrophin synthesis, and is used for the research of Duchenne muscular dystrophy.
    Tacadirsen sodium
  • HY-122631
    TG693
    Modulator 99.95%
    TG693 is an orally active inhibitor of CLK1. TG693 regulates the mutated exon 31 of the dystrophin gene in vivo. TG693 is used in Duchenne muscular dystrophy (DMD) research.
    TG693
  • HY-177564
    Delpacibart zotadirsen
    Inducer
    Delpacibart zotadirsen (Del-zota), an antibody oligonucleotide conjugate (AOC), consists of a monoclonal antibody (Delpacibart) (HY-P990051) that binds to the transferrin receptor 1 (TfR1) conjugated to a phosphorodiamidate morpholino conjugate (PMO), Delpacibart zotadirsen is designed to deliver phosphorodiamidate morpholino oligomers (PMOs) to skeletal muscle and heart tissue to specifically skip exon 44 of the dystrophin gene and enable production of near-full length dystrophin. Delpacibart zotadirsen is used for the study of myotonic dystrophy type 1 (DM1).
    Delpacibart zotadirsen
  • HY-101459
    RTC13
    98.01%
    RTC13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy (DMD).
    RTC13
  • HY-150237
    FITC-labeled Drisapersen sodium
    Inhibitor
    FITC-labeled Drisapersen (sodium) is Drisapersen labeled with FITC. Drisapersen, a antisense oligonucleotide, induces exon 51 skipping during dystrophin pre-mRNA splicing and allows synthesis of partially functional dystrophin in Duchenne muscular dystrophy (DMD) patients with amenable mutations.
    FITC-labeled Drisapersen sodium
  • HY-177658
    Renadirsen
    Inhibitor
    Renadirsen is an antisense oligonucleotide that induces robust Exon 45 skipping for Dystrophin in vivo.
    Renadirsen
  • HY-177659
    Rimigorsen
    Inhibitor
    Rimigorsen is an antisense oligonucleotide that induces skipping of exon 44 of the pre-mRNA encoding dystrophin in a Duchenne muscular dystrophy (DMD)
    Rimigorsen
  • HY-177659A
    Rimigorsen sodium
    Inhibitor
    Rimigorsen sodium is an antisense oligonucleotide that induces skipping of exon 44 of the pre-mRNA encoding dystrophin in a Duchenne muscular dystrophy (DMD)
    Rimigorsen sodium
  • HY-132586C
    Viltolarsen sodium scrambled negative control
    Modulator
    Viltolarsen sodium scrambled negative control is the sequence scrambled negative control of Viltolarsen sodium.
    Viltolarsen sodium scrambled negative control
  • HY-177658B
    Renadirsen sodium scrambled negative control
    Inhibitor
    Renadirsen sodium scrambled negative control is the sequence scrambled negative control of Renadirsen sodium.
    Renadirsen sodium scrambled negative control
  • HY-132611C
    Golodirsen sodium scrambled negative control
    Modulator
    Golodirsen sodium scrambled negative control is the sequence scrambled negative control of Golodirsen sodium.
    Golodirsen sodium scrambled negative control
  • HY-177658A
    Renadirsen sodium
    Inhibitor
    Renadirsen sodium is an antisense oligonucleotide that induces robust Exon 45 skipping for Dystrophin in vivo.
    Renadirsen sodium
  • HY-177649A
    Nivudirsen sodium
    Inhibitor
    Nivudirsen sodium is an antisense oligonucleotide that can promote the synthesis of functional dystrophin protein.
    Nivudirsen sodium